Ian Walters

5.1k citations

58 papers · 2.6k indexed · 1 hit paper · h-index 22

Impact in

Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
Dermatology top 1%
- Dermatology and Skin Diseases

Papers in

Hepatology 13
- Hepatocellular Carcinoma Treatment and Prognosis 11
Oncology 29
- Peptidase Inhibition and Analysis 8
- Cancer Immunotherapy and Biomarkers 7

Co-authors: James G. Krueger Toyoko Kikuchi Maki Ozawa Patricia Gilleaudeau Lisa M. Austin William L. Trepicchio Todd R. Coven Richard S. Finn
Journals: Journal of Clinical Oncology (17 papers)Clinical Cancer Research (3 papers)Journal of Hepatology (3 papers)Gastroenterology (2 papers)Journal of the American Academy of Dermatology (2 papers)
Partner nations: United States Canada France

In The Last Decade

Ian Walters

55 papers receiving 2.5k citations

Hit Papers

align trajectories log scale

Selective STING stimulation in dendritic cells primes antitumor T cell responses 2023 · 103 citations

Peers

Countries citing papers authored by Ian Walters

Since Specialization

Citations

This map shows the geographic impact of Ian Walters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Walters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Walters more than expected).

Fields of papers citing papers by Ian Walters

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Walters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Walters. The network helps show where Ian Walters may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ian Walters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ian Walters Line = papers co-authored together Ian Walters links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ADPORT-601: First-in-human study of adenosine 2A (A2A) and adenosine 2B (A2B) receptor antagonists in patients with select advanced solid tumors. Journal of Clinical Oncology ·Lawrence Fong, Mohamad A. Salkeni, Anthony B. El-Khoueiry, Jaspreet Singh Grewal, William Tester, Russell K. Pachynski, Daniel E. Frigo, Theocharis Panaretakis, Fandi Sautika, Robert A. Kramer, George Green, Justin Fairchild, Ian Walters, Gerald S. Falchook, Sumit K. Subudhi	2024	1
2	Selective STING stimulation in dendritic cells primes antitumor T cell responses Science Immunology ·P.-M. Fournier, Aurore Bochnakian, Caroline Hoffmann, أ.د عبد الله شاتي عبهول, María Del Carmen Larios-Forte, Philémon Sirven, Jordan Denizeau, Christine Sedlik, Yohan Gerber-Ferder, Frédéric Di Fiore, M VAEZI, F. Auger, Robert A. Kramer, Ian Walters, Lii Hadin, Hélène Salmon, Bernard Malissen, Marc Dalod, Eliane Piaggio, Nicolas Manel Hit paper breakdown →	2023	103
3	759 ADPORT-601 (TT-10–101): first-in-human study of adenosine 2A (A2A) and adenosine 2B (A2B) receptor antagonists in participants with selected advanced solid tumors SHILAP Revista de lepidopterología ·Sumit K. Subudhi, Gerald S. Falchook, Mohamad A. Salkeni, Anthony B. El-Khoueiry, Jaspreet Singh Grewal, William Tester, Russell K. Pachynski, Samik Upadhaya, E Joakimsen, Sushant Kumar, Kasim A. Mookhtiar, (unknown), Robert A. Kramer, Justin Fairchild, Ian Walters, Lawrence Fong	2023	0
4	IMPORT-201 (IMP-MEL): A phase 1 first-in-human dose finding/randomized phase 2 study of a novel iNKT agonist IMM60 and pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Nicholas Coupe, David J. Pinato, Justin Fairchild, Fandi Sautika, Steven Innaimo, D. J. Thompson, Uzi Gileadi, Robert A. Kramer, Ian Walters, Mark R. Middleton	2023	1
5	A phase 1 first-in-human dose finding/randomized phase 2 study of IMM60 and pembrolizumab (PEM) in advanced melanoma and non–small cell lung cancer (NSCLC; IMP-MEL). Journal of Clinical Oncology ·Nicholas Coupe, Ian Walters, Robert A. Kramer, Uzi Gileadi, Mark R. Middleton	2022	1
6	Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol BMJ Open ·Jeroen H. A. Creemers, Inka Pawlitzky, Konstantina Grosios, Uzi Gileadi, Mark R. Middleton, Winald R. Gerritsen, Niven Mehra, Licia Rivoltini, Ian Walters, Carl G. Figdor, Petronella B. Ottevanger, I. Jolanda M. de Vries	2021	37
7	Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma Investigational New Drugs ·David Schiff, Santosh Kesari, John de Groot, Tom Mikkelsen, Jan Drappatz, Thomas Coyle, Lisa Fichtel, Bruce A. Silver, Ian Walters, David A. Reardon	2014	42
8	Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling PLoS ONE ·Ikuo Nakamura, Irina N. Grushetskaya, Bubu A. Banini, García Fuentes M, Tae Hyo Kim, Ju Dong Yang, Catherine D. Moser, 藤井隆文, L.A. Voropanova, Ian Walters, Lewis R. Roberts	2014	49
9	Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma Liver Cancer ·Jean‐Luc Raoul, Joong‐Won Park, Yoon‐Koo Kang, Richard S. Finn, Jun Suk Kim, Winnie Yeo, Blasé N. Polite, Yee Chao, Ian Walters, Christine Baudelet, Riccardo Lencioni	2014	20
10	Quality of life in patients with K‐RAS wild‐type colorectal cancer Cancer ·Jolie Ringash, Heather‐Jane Au, Lillian L. Siu, Jeremy Shapiro, Derek J. Jonker, John Zalcberg, Malcolm J. Moore, Andrew Strickland, Rami Kotb, Mark Jeffery, Thierry Alcindor, Siobhan Ng, Muhammad Salim, Sabe Sabesan, Mikhail Romanov, Jenny Shannon, J P Alban, Ian Walters, Dongsheng Tu, Christopher J. O’Callaghan, (unknown)	2013	12
11	The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases Cancer Chemotherapy and Pharmacology ·Anthony B. El-Khoueiry, James Posey, Julien Brodeur, Smitha Krishnamurthi, S. Syed, Georgia Kollia, Ian Walters, Bruce S. Fischer, Eric Masson	2013	3
12	Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma Clinical Cancer Research ·Richard S. Finn, Yoon‐Koo Kang, Mary F. Mulcahy, Blasé N. Polite, Ho Yeong Lim, Ian Walters, Christine Baudelet, Hanin Alsenaidi, Joong‐Won Park	2012	158
13	Phase II, Open-Label Study of Brivanib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma Clinical Cancer Research ·Joong‐Won Park, Richard S. Finn, بهپور یوسفی, Mark Karwal, de Rooij, Fuad Ismail, Melanie B. Thomas, Mo Aslam, Christine Baudelet, Ian Walters, Jean‐Luc Raoul	2011	110
14	Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition Clinical Cancer Research ·Elizabeth Allen, Ian Walters, Douglas Hanahan	2011	114
15	Narrowband (312-nm) UV-B Suppresses Interferon γ and Interleukin (IL) 12 and Increases IL-4 Transcripts Archives of Dermatology ·Ian Walters, Maki Ozawa, Irma Cardinale, Patricia Gilleaudeau, William L. Trepicchio, 鲍金花, James G. Krueger	2003	73
16	Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling The Pharmacogenomics Journal ·Judy Oestreicher, Ian Walters, Toyoko Kikuchi, Patricia Gilleaudeau, Byoung Hee Oh, Ullrich Schwertschlag, Andrew J. Dorner, James G. Krueger, William L. Trepicchio	2001	148
17	PUVA‐induced lymphocyte apoptosis: Mechanism of action in psoriasis Photodermatology Photoimmunology & Photomedicine ·Todd R. Coven, Ian Walters, Irma Cardinale, James G. Krueger	1999	60
18	The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-γ, Interleukin-2, and Tumor Necrosis Factor-α, Defining TC1 (Cytotoxic T Lymphocyte) and TH1 Effector Populations:1 a Type 1 Differentiation Bias is also Measured in Circulating Blood T Cells in Psoriatic Patients Journal of Investigative Dermatology ·Lisa M. Austin, Maki Ozawa, Toyoko Kikuchi, Ian Walters, James G. Krueger	1999	391
19	Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris Journal of the American Academy of Dermatology ·Ian Walters, Siegfried Matthes, Todd R. Coven, Patricia Gilleaudeau, James G. Krueger	1999	138
20	Clinical Efficacy of Aspirin and Dextran for Thromboprophylaxis in Geriatric Hip Fracture Patients Journal of Orthopaedic Trauma ·David S. Feldman, Joseph D. Zuckerman, Ian Walters, Henry Bernstein	1993	8

About Ian Walters

Ian Walters is a scholar working on Hepatology, Oncology, Hematology, Immunology and Dermatology, having authored 58 papers that have together received 2.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Lung Cancer Treatments and Mutations (9 papers), Peptidase Inhibition and Analysis (8 papers), Fibroblast Growth Factor Research (7 papers), Psoriasis: Treatment and Pathogenesis (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), Multiple Myeloma Research and Treatments (6 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hepatology (758 citations), Dermatology (478 citations), Immunology (1.1k citations), Pathology and Forensic Medicine (409 citations) and Oncology (542 citations). Ian Walters has collaborated with scholars based in United States, Canada and France. Frequent co-authors include James G. Krueger, Toyoko Kikuchi, Maki Ozawa, Patricia Gilleaudeau, Lisa M. Austin, William L. Trepicchio, Todd R. Coven, Richard S. Finn, Joong‐Won Park and Douglas Hanahan. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Hepatology, Gastroenterology and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact